ArticleCancer immunology, immunotherapy : CII2026

Clinical characteristics, prognostic factors, and feasibility of ICI continuation in immune checkpoint inhibitor-related pneumonitis.

Keisuke Masumoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.